Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/23784
Title: A novel point-of-care test for leptospirosis based on Dual Path Platform (DPP) technology to differentiate IgM and IgG antibody responses
Authors: Lyashchenko, Konstantin P
Greenwald, Rena
Esfandiari, Javan
Nabity, Scott A
Ribeiro, Guilherme de Sousa
Medeiros, Marco Alberto
Reis, Mitermayer Galvão dos
Ko, Albert Icksang
Affilliation: Chembio Diagnostic Systems. Medford, United States of America
Chembio Diagnostic Systems. Medford, United States of America
Duke University School of Medicine. Durham, United States of America
Duke University School of Medicine. Durham, United States of America
Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Instituto de Saúde Coletiva. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Bio-Manguinhos. Rio de Janeiro, RJ, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Yale University Schools of Public Health and Medicine. New Haven, United States of America
Abstract: Introduction: Improved diagnostics for leptospirosis are urgently needed, especially for resource-poor countries where leptospirosis is a major public health problem. The gold standard serodiagnostic test, the microagglutination test or MAT, is complex, time-consuming, labor-intensive, and unavailable in remote settings. Materials and Methods: A rapid (20 minutes) serodiagnostic test for leptospirosis was developed using recombinant leptospiral immunoglobulin-like (Lig) protein fragments and a modification of the Dual Path Platform (DPP) technology, namely dual DPP (D-DPP). The distinct feature of this new immunoassay format was that the test detects separately IgM and IgG antibodies such that each response can be measured semi-quantitatively by a reflectance reader device. The test was evaluated in a pilot study using acute (n=91) and convalescent-phase (n=96) serum samples from patients with confirmed leptospirosis and control individuals (n=50) from Brazil. Results: In this evaluation study, the D-DPP assay detected 80% of patients with acute-phase leptospirosis and 100% of patients with convalescent leptospirosis. The specificity was 100%. Among acute-phase cases, 60% developed both detectable IgM and IgG antibodies, 13% had only IgM, while 7% produced only IgG antibodies. During convalescence, 77%, 0%, and 23% of leptospirosis patients developed IgM and IgG, only IgM, and only IgG antibodies, respectively. Conclusions: We designed a recombinant Lig proteinbased D-DPP assay which can rapidly identify patients with acute-phase or convalescent leptospirosis with high accuracy. The ability to detect IgM and IgG antibodies separately improves diagnostic specificity as well as detection of patients who present at different times in the course of illness. The test therefore has the potential to provide effective point-of-care diagnosis in field settings in Brazil and resource-poor countries worldwide where leptospirosis is an emerging health problem
Keywords: Leptospirosis
Public health
Humans
Conducting tests
Diagnostic
keywords: Leptospirose
Saúde pública
Humanos
Realização de testes
Diagnóstico
Issue Date: 2012
Publisher: Sociedade Brasileira de Medicina Tropical
Citation: LYASHCHENKO, K. P. et al. A novel point-of-care test for leptospirosis based on Dual Path Platform (DPP) technology to differentiate IgM and IgG antibody responses. In: Congresso Internacional de Medicina Tropical e Malária, 18 e Congresso da Sociedade Brasileira de Medicina Tropical, 48., 2012, Rio de Janeiro. Resumos... Rio de Janeiro: Sociedade Brasileira de Medicina Tropical, 2012.
Copyright: open access
Appears in Collections:Biomanguinhos - Trabalhos Apresentados em Eventos
BA - IGM - Trabalhos Apresentados em Eventos

Files in This Item:
File Description SizeFormat 
Lyashchenko KP A novel...SBMT 2012 Lept8.pdf68.56 kBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.